Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
GPRO
|
Nicholas Woodman
CEO, Chairman of the Board |
SELL
Open market or private sale
|
Indirect | 37,162 Reduced 100.0% |
$297,296
$8.0 p/Share
|
Mar 17
2022 |
|
LSAK
|
Antony C Ball |
BUY
Open market or private purchase
|
Indirect | 12,401 Added 0.1% |
$55,929
$4.51 p/Share
|
Mar 17
2022 |
|
LSAK
|
Monde Nkosi |
BUY
Open market or private purchase
|
Indirect | 12,401 Added 0.1% |
$55,929
$4.51 p/Share
|
Mar 17
2022 |
|
XCLIX
|
David H Marquardt |
BUY
Open market or private purchase
|
Direct | 506 Added 50.0% |
$4,999
$9.88 p/Share
|
Mar 17
2022 |
|
NVCT
|
Ron Bentsur
Chairman & CEO |
BUY
Open market or private purchase
|
Direct | 7,000 Added 0.25% |
$53,410
$7.63 p/Share
|
Mar 17
2022 |
|
NNUP
|
Matthew C. Winger
Chief Executive Officer |
BUY
Open market or private purchase
|
Direct | 5,000 Added 0.87% |
$950
$0.19 p/Share
|
Mar 17
2022 |
|
CING
|
Peter J. Werth
Director |
BUY
Open market or private purchase
|
Indirect | 27,000 Added 3.0% |
$48,330
$1.79 p/Share
|
Mar 17
2022 |
|
NUZE
|
Kevin J Conner
Director |
BUY
Grant, award, or other acquisition
|
Direct | 23,584 Added 50.0% |
-
|
Mar 17
2022 |
|
NUZE
|
David Robson
Director |
BUY
Grant, award, or other acquisition
|
Direct | 23,584 Added 50.0% |
-
|
Mar 17
2022 |
|
NUZE
|
Nobuki Kurita
Director |
BUY
Grant, award, or other acquisition
|
Direct | 23,584 Added 50.0% |
-
|
Mar 17
2022 |
|
NUZE
|
James Chris Jones
Director |
BUY
Grant, award, or other acquisition
|
Direct | 23,584 Added 50.0% |
-
|
Mar 17
2022 |
|
NUZE
|
Tracy Ging
Director |
BUY
Grant, award, or other acquisition
|
Direct | 23,584 Added 50.0% |
-
|
Mar 17
2022 |
|
BJDX
|
Douglas Clark Wurth
Director |
BUY
Open market or private purchase
|
Direct | 40,000 Added 1.72% |
$47,200
$1.18 p/Share
|
Mar 17
2022 |
|
EDSA
|
Pardeep Nijhawan
Chief Executive Officer |
BUY
Open market or private purchase
|
Direct | 2,000 Added 0.36% |
$6,520
$3.26 p/Share
|
Mar 17
2022 |
|
VYNE
|
David Domzalski
PRESIDENT AND CEO |
BUY
Grant, award, or other acquisition
|
Direct | 312,302 Added 22.55% |
-
|
Mar 17
2022 |
|
VYNE
|
Mutya Harsch
CHIEF LEGAL OFFICER AND GC |
BUY
Grant, award, or other acquisition
|
Direct | 75,000 Added 23.95% |
-
|
Mar 17
2022 |
|
VYNE
|
Iain Stuart
CHIEF SCIENTIFIC OFFICER |
BUY
Grant, award, or other acquisition
|
Direct | 75,000 Added 24.68% |
-
|
Mar 17
2022 |
|
VYNE
|
Tyler Zeronda
CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct | 75,000 Added 31.6% |
-
|
Mar 17
2022 |
|
LTBR
|
Seth Grae
President and CEO |
BUY
Grant, award, or other acquisition
|
Direct | 331 Added 0.27% |
$3,012
$9.1 p/Share
|
Mar 17
2022 |
|
LTBR
|
Larry Goldman
CFO |
BUY
Grant, award, or other acquisition
|
Direct | 136 Added 0.22% |
$1,238
$9.1 p/Share
|
Mar 17
2022 |
|
LTBR
|
Andrey Mushakov
EVP, Nuclear Operations |
BUY
Grant, award, or other acquisition
|
Direct | 147 Added 0.2% |
$1,338
$9.1 p/Share
|
Mar 17
2022 |
|
MTBC
|
A Hadi Chaudhry
CEO |
SELL
Open market or private sale
|
Direct | 3,240 Reduced 50.0% |
$82,879
$25.58 p/Share
|
Mar 17
2022 |
|
HOFV
|
Mary Owen
Director |
BUY
Open market or private purchase
|
Direct | 5,000 Added 4.94% |
$5,100
$1.02 p/Share
|
Mar 17
2022 |
|
HOFV
|
Karl L Holz
Director |
BUY
Open market or private purchase
|
Direct | 20,000 Added 14.57% |
$20,600
$1.03 p/Share
|
Mar 17
2022 |
|
ATHX
|
Ivor Macleod
Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 1,292 Reduced 0.89% |
$1,072
$0.83 p/Share
|
Mar 17
2022 |
|
ATHX
|
William Lehmann Jr
President, COO |
SELL
Payment of exercise price or tax liability
|
Direct | 7,258 Reduced 1.53% |
$6,024
$0.83 p/Share
|
Mar 17
2022 |
|
ATHX
|
John J Harrington
Exec Vice Pres and CSO |
SELL
Payment of exercise price or tax liability
|
Direct | 13,893 Reduced 1.94% |
$11,531
$0.83 p/Share
|
Mar 17
2022 |
|
NCMI
|
Kurt C Hall
Director |
BUY
Grant, award, or other acquisition
|
Direct | 2,675 Added 0.36% |
$6,928
$2.59 p/Share
|
Mar 17
2022 |
|
LSBK
|
Tracy Steve Bennett
Director |
BUY
Grant, award, or other acquisition
|
Direct | 541 Added 4.81% |
-
|
Mar 17
2022 |
|
LSBK
|
Sharon E Brautigam |
BUY
Grant, award, or other acquisition
|
Direct | 536 Added 3.63% |
-
|
Mar 17
2022 |
|
LSBK
|
John P Mc Grath |
BUY
Grant, award, or other acquisition
|
Direct | 514 Added 29.83% |
-
|
Mar 17
2022 |
|
LSBK
|
John L Mehltretter |
BUY
Grant, award, or other acquisition
|
Direct | 514 Added 8.93% |
-
|
Mar 17
2022 |
|
LSBK
|
Ronald J Passafaro |
BUY
Grant, award, or other acquisition
|
Direct | 536 Added 19.11% |
-
|
Mar 17
2022 |
|
LSBK
|
Kevin M. Sanvidge |
BUY
Grant, award, or other acquisition
|
Direct | 950 Added 7.39% |
-
|
Mar 17
2022 |
|
LSBK
|
Nancy L Yocum
Director |
BUY
Grant, award, or other acquisition
|
Direct | 554 Added 3.29% |
-
|
Mar 17
2022 |
|
LSBK
|
Catharine M Young
Director |
BUY
Grant, award, or other acquisition
|
Direct | 432 Added 44.81% |
-
|
Mar 17
2022 |
|
RDI
|
Margaret Cotter
Chairperson, EVP - RE Dev/NY |
SELL
Open market or private sale
|
Indirect | 2,750 Reduced 0.21% |
$12,072
$4.39 p/Share
|
Mar 17
2022 |
|
RDI
|
Ellen M Cotter
Director, President and CEO |
SELL
Open market or private sale
|
Indirect | 2,750 Reduced 0.21% |
$12,072
$4.39 p/Share
|
Mar 17
2022 |
|
RDI
|
James J. Cotter Living Trust
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 2,750 Reduced 0.21% |
$12,072
$4.39 p/Share
|
Mar 17
2022 |
|
PBHC
|
Adam C. Gagas |
BUY
Open market or private purchase
|
Direct | 1,500 Added 6.96% |
$26,625
$17.75 p/Share
|
Mar 17
2022 |
|
CWBC
|
Timothy Joseph Stronks
EVP Chief Operating Officer |
BUY
Open market or private purchase
|
Direct | 1,500 Added 37.5% |
$21,090
$14.06 p/Share
|
Mar 17
2022 |
|
HYFM
|
Bruce John Lindeman
Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 2,308 Reduced 0.71% |
$34,320
$14.87 p/Share
|
Mar 17
2022 |
|
FGBI
|
Marshall T Reynolds
Director |
SELL
Open market or private sale
|
Indirect | 1,390 Reduced 9.09% |
$30,802
$22.16 p/Share
|
Mar 17
2022 |
|
ARDC
|
Bruce H Spector
Director |
BUY
Open market or private purchase
|
Direct | 10,000 Added 22.22% |
$141,800
$14.18 p/Share
|
Mar 17
2022 |
|
AVNW
|
Bruce M. Taten
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,335 Added 28.59% |
-
|
Mar 17
2022 |
|
LSEA
|
Qin Zhou
Director |
BUY
Open market or private purchase
|
Direct | 570 Added 4.45% |
$5,067
$8.89 p/Share
|
Mar 17
2022 |
|
LSEA
|
John Ho
Chief Executive Officer |
BUY
Open market or private purchase
|
Direct | 30,769 Added 5.82% |
$274,152
$8.91 p/Share
|
Mar 17
2022 |
|
CIVB
|
Allen R Nickles |
SELL
Other acquisition or disposition
|
Indirect | 725 Reduced 100.0% |
-
|
Mar 17
2022 |
|
ARIS
|
Joseph Colonnetta |
BUY
Open market or private purchase
|
Direct | 5,000 Added 28.26% |
$89,350
$17.87 p/Share
|
Mar 17
2022 |
|
CARE
|
Arthur Loran Adams
EVP, DIRECTOR OF REG RISK MNGT |
BUY
Grant, award, or other acquisition
|
Direct | 1,500 Added 19.39% |
-
|
Mar 17
2022 |